Ningbo Menovo Stock Hits Day Low of CNY 49.50 Amid Price Pressure

Ningbo Menovo Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 5.1% as it reached an intraday low of CNY 49.50. This performance contrasts with the China Shanghai Composite, which saw a slight increase of 0.87% on the same day. Over the past week, Ningbo Menovo's stock has decreased by 0.71%, while its monthly performance reflects a marginal decline of 0.12%. However, the company has shown impressive growth over the past year, boasting a remarkable 255.21% increase, significantly outperforming the China Shanghai Composite's 21.68% gain. Despite its recent downturn, Ningbo Menovo has demonstrated strong returns over the last three years, with a 144.14% increase. The company maintains a market capitalization of CNY 10,727 million and a price-to-earnings ratio of 53.00. Its return on equity stands at 4.97%, indicating a moderate level of profitability. Additionally, the stock offers a dividend yield of 0.10%, reflecting its commitment to shareholder returns amidst fluctuating market conditions.